X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5266) 5266
Publication (814) 814
Book Chapter (98) 98
Book Review (58) 58
Conference Proceeding (52) 52
Dissertation (40) 40
Book / eBook (10) 10
Government Document (10) 10
Web Resource (6) 6
Magazine Article (3) 3
Streaming Video (3) 3
Trade Publication Article (2) 2
Data Set (1) 1
Journal / eJournal (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3449) 3449
index medicus (2829) 2829
animals (2617) 2617
cancer (1812) 1812
oncology (1802) 1802
mice (1767) 1767
cell line, tumor (1537) 1537
oncolytic virotherapy (1525) 1525
oncolytic virotherapy - methods (1368) 1368
medicine, research & experimental (1260) 1260
viruses (1078) 1078
biotechnology & applied microbiology (1044) 1044
oncolytic virus (1013) 1013
oncolytic viruses - genetics (1004) 1004
female (1000) 1000
health aspects (946) 946
genetics & heredity (928) 928
gene therapy (924) 924
neoplasms - therapy (914) 914
tumors (901) 901
immunotherapy (893) 893
adenoviridae - genetics (872) 872
therapy (802) 802
apoptosis (801) 801
care and treatment (775) 775
oncolytic adenovirus (770) 770
mice, nude (756) 756
virus replication (754) 754
xenograft model antitumor assays (731) 731
research (717) 717
oncolytic viruses (658) 658
adenovirus (651) 651
oncolysis (620) 620
virotherapy (607) 607
male (598) 598
oncolytic viruses - physiology (589) 589
article (573) 573
adenoviruses (542) 542
in-vivo (540) 540
expression (529) 529
genetic therapy - methods (525) 525
cells (486) 486
gene expression (478) 478
genetic aspects (478) 478
gene-therapy (471) 471
virology (471) 471
replication (465) 465
genetic vectors (462) 462
chemotherapy (451) 451
biochemistry & molecular biology (426) 426
herpes-simplex-virus (411) 411
mice, inbred balb c (405) 405
cancer therapies (398) 398
genetic vectors - genetics (381) 381
combined modality therapy (373) 373
proteins (367) 367
melanoma (361) 361
genetic therapy (351) 351
cell biology (343) 343
adenoviridae - physiology (333) 333
genetics (323) 323
analysis (307) 307
clinical trials (307) 307
review (303) 303
molecular biology (302) 302
immunology (301) 301
infection (296) 296
pharmacology (296) 296
phase-i trial (291) 291
disease models, animal (288) 288
molecular medicine (282) 282
metastasis (281) 281
neoplasms - genetics (271) 271
oncolytic (271) 271
vesicular stomatitis-virus (270) 270
phase-i (269) 269
cell line (264) 264
drug discovery (260) 260
oncolytic viruses - immunology (259) 259
neoplasms - immunology (258) 258
usage (255) 255
neoplasms - virology (253) 253
tumor-cells (253) 253
neoplasms. tumors. oncology. including cancer and carcinogens (248) 248
treatment outcome (246) 246
original (245) 245
virus (245) 245
cytotoxicity (244) 244
pharmacology & pharmacy (244) 244
infections (241) 241
vectors (237) 237
tumor cells, cultured (236) 236
brain neoplasms - therapy (234) 234
dendritic cells (231) 231
biology (230) 230
efficacy (230) 230
mice, inbred c57bl (225) 225
genetic engineering (224) 224
glioma (223) 223
neoplasms - pathology (223) 223
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5240) 5240
Chinese (43) 43
Japanese (38) 38
German (18) 18
Russian (18) 18
French (13) 13
Korean (10) 10
Polish (6) 6
Spanish (6) 6
Hungarian (5) 5
Croatian (1) 1
Persian (1) 1
Portuguese (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2012
Source: National Library of New Zealand Te Puna Matauranga o Aotearoa, licensed by the Department of Internal Affairs for re-use under the Creative Commons... 
Viruses | Treatment | Therapeutic use | Cancer
eJournal
Cancer Science, ISSN 1347-9032, 10/2016, Volume 107, Issue 10, pp. 1373 - 1379
Journal Article
Journal of Controlled Release, ISSN 0168-3659, 12/2015, Volume 220, Issue Pt B, pp. 766 - 782
Pancreatic cancer is highly aggressive, malignant, and notoriously difficult to cure using conventional cancer therapies. These conventional therapies have... 
Systemic administration | Neurotensin | Pancreatic cancer | Oncolytic adenovirus | GENE DELIVERY | VIVO | CELLS IN-VITRO | ADENOCARCINOMA | BIODISTRIBUTION | ANTIBODY EVASION ABILITY | CANCER | CHEMISTRY, MULTIDISCIPLINARY | THERAPY | TROPISM | PHARMACOLOGY & PHARMACY | VECTORS | Pancreatic Neoplasms - metabolism | Receptors, Neurotensin - metabolism | Humans | Male | Polyethylene Glycols - chemistry | Neurotensin - immunology | Viral Load | Oncolytic Viruses - growth & development | Time Factors | Adenoviridae - genetics | Neurotensin - biosynthesis | Oncolytic Virotherapy - adverse effects | Decorin - genetics | Decorin - biosynthesis | Pancreatic Neoplasms - virology | Adaptive Immunity | Transduction, Genetic | Cell Survival | Pancreatic Neoplasms - pathology | Oncolytic Viruses - genetics | Pancreatic Neoplasms - genetics | Immunity, Innate | Oncolytic Viruses - metabolism | Xenograft Model Antitumor Assays | Neurotensin - genetics | Oncolytic Virotherapy - methods | Animals | Tumor Burden - drug effects | Virus Replication | Wnt Signaling Pathway - genetics | Gene Expression Regulation, Viral | Mice, Nude | Adenoviridae - growth & development | Oncolytic Viruses - immunology | Cell Line, Tumor | Adenoviridae - metabolism | Genetic Therapy - adverse effects | Genetic Therapy - methods | Pancreatic Neoplasms - therapy | Adenoviruses | Therapeutics | Neuropeptides | Polyols | Homeopathy | Materia medica and therapeutics
Journal Article
Expert Opinion on Biological Therapy, ISSN 1471-2598, 03/2017, Volume 17, Issue 3, pp. 353 - 363
Journal Article
Cancer Biology & Therapy, ISSN 1538-4047, 09/2014, Volume 15, Issue 9, pp. 1226 - 1238
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 9/2008, Volume 105, Issue 39, pp. 14981 - 14986
Intratumoral innate immunity can play a significant role in blocking the effective therapeutic spread of a number of oncolytic viruses (OVs). Histone... 
Oncolytic viruses | Tumor cell line | Histone deacetylase inhibitors | Antivirals | Cell lines | Viruses | Infections | Tumors | Cancer | Apoptosis | HDAC inhibitor | Oncolytic virus | Combination therapy | Refractory tumors | IMMUNE-RESPONSE | SUBEROYLANILIDE HYDROXAMIC ACID | MULTIDISCIPLINARY SCIENCES | ANTICANCER AGENT | T-CELL LYMPHOMA | DRUG INSIGHT | VESICULAR-STOMATITIS-VIRUS | PHASE-I TRIAL | SIGNALING PATHWAY | oncolytic virus | NEGATIVE REGULATION | GENE-EXPRESSION | refractory tumors | combination therapy | Vesiculovirus - drug effects | Humans | Vesiculovirus - immunology | Male | Prostatic Neoplasms - virology | Prostatic Neoplasms - therapy | Neoplasms - virology | Neoplasms - therapy | Benzamides - therapeutic use | Female | Oncolytic Viruses - drug effects | Prostatic Neoplasms - drug therapy | Disease Models, Animal | Pyridines - therapeutic use | Virus Replication - drug effects | Immunity, Innate - drug effects | Mice, Inbred Strains | Enzyme Inhibitors - therapeutic use | Oncolytic Virotherapy | Neoplasms - drug therapy | Xenograft Model Antitumor Assays | Interferons - administration & dosage | Animals | Oncolytic Viruses - immunology | Oncolytic Viruses - physiology | Cell Line, Tumor | Histone Deacetylase Inhibitors | Mice | Vesiculovirus - physiology | Usage | Histones | Drug targeting | Research | Health aspects | Immunity | Biological Sciences
Journal Article
Journal Article